Preferred Label : testosterone;

MeSH definition : A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.;

MeSH synonym : 17-beta-hydroxy-4-androsten-3-one; 17 beta hydroxy 4 androsten 3 one;

CISMeF synonym : dr. kade brand of testosterone; hauck brand of testosterone; ulmer brand of testosterone; watson brand of testosterone; faulding brand of testosterone; paladin brand of testosterone; AstraZeneca brand of testosterone; CEPA brand of testosterone; ortho brand of testosterone; ferring brand of testosterone; pasadena brand of testosterone; bartor brand of testosterone; solvay brand of testosterone; unimed brand of testosterone; schering brand of testosterone; SmithKline beecham brand of testosterone; GlaxoSmithKline brand of testosterone; auxilium pharmaceuticals inc. brand of testosterone;

MeSH hyponym : testolin; testopel; androderm; sustanon; androtop; histerone; testim; testoderm; testosterone sulfate; sterotate; AndroGel; andropatch;

Related MeSH term : 8-Isotestosterone; 8 Isotestosterone; 17-beta-Hydroxy-8 alpha-4-Androsten-3-one; 17 beta Hydroxy 8 alpha 4 Androsten 3 one;

MeSH CAS label : Androst-4-en-17beta-ol-3-one;

MeSH Related Number : 58-22-0 (Testosterone);

Registry Number MeSH : 58-22-0;

MeSH annotation : TESTOSTERONE PROPIONATE is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Testosterone;

Codes EINECS : 200-370-5;

Is substance : O;

UNII : 3XMK78S47O;

InChIKey : MUMGGOZAMZWBJJ-DYKIIFRCSA-N;

Details


Main resources

You can consult :

A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.

https://ansm.sante.fr/tableau-marr/testoserone-undecanoate-de
2023
false
false
false
France
French
guidelines for drug use
testosterone undecanoate
testosterone
testosterone
testosterone
testosterone

---
https://www.has-sante.fr/jcms/p_3479053/fr/testosterone-besins-testosterone-hypogonadisme-masculin
2023
false
false
false
France
eunuchoidism
testosterone undecanoate
treatment outcome
insurance, health, reimbursement
hormone replacement therapy
testosterone
testosterone
androgens
evaluation of the transparency committee
eunuchism
testosterone

---
https://ansm.sante.fr/actualites/medicaments-a-base-de-testosterone-la-prescription-initiale-est-elargie
2022
false
false
false
France
French
drug information
testosterone
drug prescriptions
hypogonadism
testosterone
testosterone
androgens
Male

---
https://www.urofrance.org/wp-content/uploads/2021/11/Item-124-Andropause.pdf
2021
France
educational course
male climacteric
age, nos
testosterone
testosterone
andropause

---
https://orbi.uliege.be/handle/2268/230114
2018
Belgium
journal article
testosterone
testosterone

---
https://primary-hospital-care.ch/fr/article/doi/phc-f.2018.01750/
2018
false
false
false
Switzerland
French
journal article
hypogonadism
testosterone

---
https://www.has-sante.fr/portail/jcms/c_2881379/fr/pantestone
2018
false
true
false
France
insurance, health, reimbursement
testosterone undecanoate
testosterone
hypogonadism
administration, oral
androgens
evaluation of the transparency committee
testosterone
testosterone

---
http://www.revmed.ch/RMS/2014/RMS-N-432/La-testosterone-un-traitement-pour-la-prevention-des-ma-ladies-cardiovasculaires
2014
false
false
false
Switzerland
French
testosterone
hypogonadism
testosterone
cardiovascular diseases
risk
journal article
testosterone
testosterone

---
http://www.sciencedirect.com/science/article/pii/S0755498213007720
2014
false
false
false
France
French
health technology assessment
testosterone
obesity
diabetes mellitus
obesity, nos
syndrome
metabolism
mass media
medical
general metabolic function, nos
disease, nos
obesity
testosterone
Metabolic Syndrome
syndrome
metabolism

---
http://www.extenso.org/article/manger-trop-de-soya-peut-diminuer-la-testosterone/
2014
false
false
false
popular works
testosterone
eating
Glycine max

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40587a-fra.php
2014
false
false
false
Canada
French
English
testosterone
pharmacovigilance note
cardiovascular diseases
testosterone
androgens
patient education handout
androgens
testosterone
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_893164/pantestone
http://www.has-sante.fr/portail/jcms/c_1647776/fr/pantestone
http://www.has-sante.fr/portail/jcms/c_1647775/fr/pantestone-04092013-avis-ct13073
2013
France
French
testosterone undecanoate
testosterone
administration, oral
androgens
hypogonadism
insurance, health, reimbursement
testosterone
hormone replacement therapy
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_944559/androtardyl
http://www.has-sante.fr/portail/jcms/c_1647770/fr/androtardyl
http://www.has-sante.fr/portail/jcms/c_1647769/fr/androtardyl-04092013-avis-ct13089
2013
France
French
hypogonadism
androgens
injections, intramuscular
insurance, health, reimbursement
testosterone
testosterone
testosterone enanthate
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Livensa
2012
United Kingdom
French
English
syndication feed
hysterectomy
ovariectomy
testosterone
testosterone
androgens
androgens
treatment outcome
drug evaluation
drug approval
drug labeling
libido
sexual dysfunction, physiological
pregnancy
testosterone
drug evaluation
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Intrinsa
2012
United Kingdom
English
French
syndication feed
treatment outcome
drug evaluation
testosterone
sexual dysfunction, physiological
administration, cutaneous
Intrinsa
testosterone
testosterone
Intrinsa
drug approval
package leaflet
summary of product characteristics
drug evaluation

---
https://www.amub-ulb.be/system/files/rmb/old/859
2012
Belgium
French
andropause
testosterone
testosterone
journal article

---
https://www.revmed.ch/RMS/2012/RMS-363/Bronchopneumopathie-chronique-obstructive-risques-et-benefices-d-un-traitement-de-testosterone
2012
Switzerland
French
pulmonary disease, chronic obstructive
testosterone
journal article
androgens

---
http://www.cochrane.org/fr/CD000188
2012
United Kingdom
France
French
meta-analysis
atherosclerosis
lower extremity
treatment outcome
testosterone
intermittent claudication
peripheral vascular diseases
french abstract

---
https://medicalforum.ch/fr/detail/doi/fms.2011.07714
2011
false
true
false
Switzerland
aged
men
testosterone
journal article
androgens

---
http://www.cochrane.org/fr/CD004509
2010
false
true
false
France
United Kingdom
treatment outcome
review of literature
french abstract
perimenopause
postmenopause
testosterone

---
http://www.senat.fr/noticerap/2009/lc202-notice.html
http://www.senat.fr/lc/lc202/lc202_mono.html
2009
France
French
germany
United Kingdom
belgium
denmark
spain
poland
sweden
sex offenses
sex offenses
testosterone
drug therapy
comparative study

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-01/intrinsa_-_ct-6937.pdf
http://www.has-sante.fr/portail/jcms/c_923737/intrinsa-dispositif-transdermique-testosterone
2009
Haute Autorité de santé
France
French
testosterone
androgens
Intrinsa
testosterone
administration, cutaneous
androgens
sexual dysfunction, physiological
Intrinsa
testosterone
insurance, health, reimbursement
hormone replacement therapy
ovariectomy
hysterectomy
drug therapy, combination
treatment outcome
transdermal patch
testosterone
guidelines for drug use
evaluation of the transparency committee
French pre-residency program examination

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F35F02H
2008
Belgium
journal article
dehydroepiandrosterone
testosterone

---
http://www.meddispar.fr/medicaments/3706798
2008
France
French
testosterone
administration, cutaneous
drug prescriptions
legislation, drug
testosterone
drug information

---
http://www.meddispar.fr/medicaments/3706700
2008
France
French
testosterone
administration, cutaneous
drug prescriptions
legislation, drug
testosterone
drug information

---
http://www.meddispar.fr/medicaments/3575362
2008
France
French
administration, cutaneous
drug prescriptions
testosterone
legislation, drug
testosterone
drug information

---
http://www.meddispar.fr/medicaments/3575385
2008
France
French
drug prescriptions
gels
testosterone
administration, cutaneous
legislation, drug
testosterone
drug information

---
http://www.meddispar.fr/medicaments/3706752
2008
France
French
testosterone
administration, cutaneous
drug prescriptions
legislation, drug
testosterone
drug information

---
http://www.meddispar.fr/medicaments/3776480
2007
France
French
testosterone
administration, oral
drug prescriptions
legislation, drug
testosterone undecanoate
testosterone
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_487010
2007
France
French
adult
treatment outcome
testosterone
administration, cutaneous
hypogonadism
testosterone
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_474436
http://www.has-sante.fr/portail/display.jsp?id=c_474438
2006
France
French
testosterone congeners
testosterone
hypogonadism
testosterone
injections, intramuscular
adult
aged
testosterone undecanoate
testosterone
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct020963.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_399409
2002
France
French
testosterone
administration, cutaneous
androgens
hypogonadism
testosterone
insurance, health, reimbursement
treatment outcome
gels
evaluation of the transparency committee

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.